Guardian Pharmacy Services (NYSE:GRDN) Stock Price Down 6.9% – What’s Next?

Guardian Pharmacy Services, Inc. (NYSE:GRDN)’s share price traded down 6.9% during mid-day trading on Friday . The company traded as low as $27.70 and last traded at $27.46. 232,289 shares were traded during mid-day trading, a decline of 16% from the average session volume of 274,956 shares. The stock had previously closed at $29.50.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the stock. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Guardian Pharmacy Services in a report on Monday, December 29th. Oppenheimer began coverage on shares of Guardian Pharmacy Services in a research report on Friday, October 10th. They set an “outperform” rating and a $30.00 price target for the company. Wall Street Zen upgraded Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a report on Monday, November 17th. Truist Financial boosted their price objective on Guardian Pharmacy Services from $30.00 to $34.00 and gave the stock a “buy” rating in a research note on Friday, November 14th. Finally, Stephens raised their target price on Guardian Pharmacy Services from $35.00 to $36.00 and gave the company an “overweight” rating in a research report on Wednesday. Four investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $32.00.

Guardian Pharmacy Services Stock Performance

The company has a market cap of $1.71 billion, a PE ratio of 42.75 and a beta of 0.96. The firm’s 50 day moving average is $29.95 and its 200-day moving average is $26.47.

Guardian Pharmacy Services (NYSE:GRDN) last released its earnings results on Monday, November 10th. The company reported $0.25 earnings per share for the quarter, topping analysts’ consensus estimates of $0.24 by $0.01. The business had revenue of $377.43 million for the quarter, compared to analyst estimates of $381.16 million. Guardian Pharmacy Services had a net margin of 2.90% and a return on equity of 30.29%. On average, analysts predict that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current year.

Institutional Trading of Guardian Pharmacy Services

A number of hedge funds and other institutional investors have recently modified their holdings of GRDN. State of Alaska Department of Revenue purchased a new position in shares of Guardian Pharmacy Services during the 3rd quarter worth $30,000. Parkside Financial Bank & Trust acquired a new stake in Guardian Pharmacy Services during the second quarter worth about $41,000. Ameritas Investment Partners Inc. raised its stake in Guardian Pharmacy Services by 26.5% during the third quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock worth $43,000 after purchasing an additional 345 shares during the period. Raymond James Financial Inc. acquired a new position in Guardian Pharmacy Services in the 2nd quarter valued at about $43,000. Finally, Police & Firemen s Retirement System of New Jersey grew its stake in shares of Guardian Pharmacy Services by 76.8% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 2,444 shares of the company’s stock valued at $52,000 after buying an additional 1,062 shares during the period.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.